Page last updated: 2024-08-21

quinazolines and B16 Melanoma

quinazolines has been researched along with B16 Melanoma in 21 studies

Research

Studies (21)

TimeframeStudies, this research(%)All Research%
pre-19901 (4.76)18.7374
1990's3 (14.29)18.2507
2000's6 (28.57)29.6817
2010's8 (38.10)24.3611
2020's3 (14.29)2.80

Authors

AuthorsStudies
Fenical, W; Hillman, PF; Kim, MJ; Lee, SE; Lim, KM; Nam, SJ; Oh, DC1
Dai, W; He, B; Meng, X; Qin, M; Wang, D; Wang, X; Yang, C; Zhang, H; Zhang, Q; Zheng, Q1
Choi, Y; Lin, H; Lin, L; Michniak-Kohn, B1
Deriabin, P; Dezhenkova, L; Gerasimenko, A; Grammatikova, N; Kaluzhny, D; Klimovich, A; Moskovkina, T; Popov, A; Shchekotikhin, A; Stonik, V; Styshova, O; Udovenko, A1
Chen, CM; Cheng, CY; Lin, KY; Lu, CY; Wu, YH1
Fu, F; Kong, X; Sun, S; Wang, H; Wang, N; Yao, J; Zhang, J1
Barry, ST; Campbell, H; Critchlow, SE; Eberlein, C; Farren, M; Frith, J; Huby, R; Kendrew, J; Michopoulos, F; Morgan, S; Patel, B; Pommier, AJ; Robertson, J; Smith, NR; Smith, PD; Wappett, M; Womack, C1
Hoeller, C; Kunstfeld, R; Loewe, R; Paulitschke, V; Pehamberger, H; Pilarski, P; Schicher, N; Swoboda, A1
Li, S; Wang, C; Wang, MW1
Bang, SC; Hwang, BY; Jung, SH; Kim, Y; Lee, JH; Lee, KC; Roh, E; Thanigaimalai, P; Yun, CY1
Cao, Z; Cheng, L; Dai, L; Deng, H; Deng, S; Feng, S; Li, W; Liu, S; Liu, Y; Ma, Y; Pan, Y; Shen, G; Shi, S; Tian, H; Wang, W; Wei, Y; Xie, H; Yang, S; Yang, Y; Zhang, N; Zhang, S; Zhao, C; Zhao, X; Zheng, R1
Langenkamp, E; Leenders, WP; Molema, G; Moorlag, HE; St Croix, B; Zwiers, PJ1
Matsunaga, T; Ogasawara, M; Saiki, I; Suzuki, H; Takahashi, S1
Ogasawara, M; Suzuki, H1
Jantová, S; Mikulásová, M; Theiszová, M1
Jantová, S; Letasiová, S; Múcková, M; Ovádeková, R1
Genady, AR1
Chen, XH; Dai, ZR; Liu, JQ; Xu, XG; Yu, AZ; Zhang, XP1
Atassi, G; Baron, M; Bissery, MC; Cros, S; Gebel-Servolles, P; Giorgi-Renault, S; Lavelle, F; Paoletti, C; Renault, J1
Osada, Y; Tanaka, NG; Tohgo, A1
Atassi, G; Dumont, P; Kabbe, HJ; Yoder, O1

Other Studies

21 other study(ies) available for quinazolines and B16 Melanoma

ArticleYear
Deoxyvasicinone with Anti-Melanogenic Activity from Marine-Derived
    Marine drugs, 2022, Feb-21, Volume: 20, Issue:2

    Topics: Animals; Cell Line, Tumor; Down-Regulation; Humans; Melanins; Melanocytes; Melanoma; Melanoma, Experimental; Mice; Quinazolines; Skin; Streptomyces

2022
Nano-encapsulated tryptanthrin derivative for combined anticancer therapy via inhibiting indoleamine 2,3-dioxygenase and inducing immunogenic cell death.
    Nanomedicine (London, England), 2019, Volume: 14, Issue:18

    Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Female; HeLa Cells; Humans; Immunogenic Cell Death; Indoleamine-Pyrrole 2,3,-Dioxygenase; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Nanocapsules; Neoplasms; Polyesters; Quinazolines; Tumor Burden

2019
Development and in-vitro evaluation of co-loaded berberine chloride and evodiamine ethosomes for treatment of melanoma.
    International journal of pharmaceutics, 2020, May-15, Volume: 581

    Topics: Animals; Berberine; Drug Delivery Systems; Drug Development; Female; Humans; Liposomes; Melanoma, Experimental; Mice; Middle Aged; Plant Extracts; Quinazolines; Skin Absorption

2020
Design, synthesis and biomedical evaluation of mostotrin, a new water soluble tryptanthrin derivative.
    International journal of molecular medicine, 2020, Volume: 46, Issue:4

    Topics: Animals; Anti-Infective Agents; Antineoplastic Agents; Cell Line, Tumor; Doxorubicin; Female; HCT116 Cells; Humans; K562 Cells; MCF-7 Cells; Melanoma, Experimental; Mice; Mice, Inbred BALB C; Quinazolines; Structure-Activity Relationship; Water

2020
Regulation of miR-21 expression in human melanoma via UV-ray-induced melanin pigmentation.
    Environmental toxicology, 2017, Volume: 32, Issue:8

    Topics: alpha-MSH; Animals; Cell Line, Tumor; Down-Regulation; ErbB Receptors; Gefitinib; Humans; Melanins; Melanoma; Melanoma, Experimental; Mice; MicroRNAs; Phosphorylation; Pigmentation; Proto-Oncogene Proteins c-akt; Quinazolines; Signal Transduction; Skin Neoplasms; Ultraviolet Rays

2017
Design and Discovery of Quinazoline- and Thiourea-Containing Sorafenib Analogs as EGFR and VEGFR-2 Dual TK Inhibitors.
    Molecules (Basel, Switzerland), 2017, Dec-23, Volume: 23, Issue:1

    Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Design; ErbB Receptors; Humans; Melanoma, Experimental; Mice, Inbred C57BL; Molecular Docking Simulation; Protein Binding; Quinazolines; Sorafenib; Thiourea; Vascular Endothelial Growth Factor Receptor-2; Xenograft Model Antitumor Assays

2017
Leptin, BMI, and a Metabolic Gene Expression Signature Associated with Clinical Outcome to VEGF Inhibition in Colorectal Cancer.
    Cell metabolism, 2016, Jan-12, Volume: 23, Issue:1

    Topics: Animals; Antineoplastic Agents; Biomarkers, Tumor; Body Mass Index; Cell Line, Tumor; Colorectal Neoplasms; Humans; Kaplan-Meier Estimate; Leptin; Melanoma, Experimental; Mice; Mice, Obese; Proportional Hazards Models; Quinazolines; Retrospective Studies; Transcriptome; Treatment Outcome; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays

2016
Erlotinib and bevacizumab have synergistic activity against melanoma.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2009, May-15, Volume: 15, Issue:10

    Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Cell Line; Cell Line, Tumor; Cell Movement; Cell Proliferation; Drug Synergism; ErbB Receptors; Erlotinib Hydrochloride; Extracellular Signal-Regulated MAP Kinases; Female; Humans; Immunoblotting; Immunohistochemistry; Ki-67 Antigen; Lung Neoplasms; Melanoma, Experimental; Mice; Mice, SCID; Platelet Endothelial Cell Adhesion Molecule-1; Proto-Oncogene Proteins c-akt; Quinazolines; Signal Transduction; Tumor Burden; Xenograft Model Antitumor Assays

2009
Evodiamine-induced human melanoma A375-S2 cell death was mediated by PI3K/Akt/caspase and Fas-L/NF-kappaB signaling pathways and augmented by ubiquitin-proteasome inhibition.
    Toxicology in vitro : an international journal published in association with BIBRA, 2010, Volume: 24, Issue:3

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Biotransformation; Blotting, Western; Caspases; Cell Death; Cell Line, Tumor; Cell Survival; Coloring Agents; Extracellular Signal-Regulated MAP Kinases; Fas Ligand Protein; Humans; Melanoma, Experimental; NF-kappa B; Oncogene Protein v-akt; Phosphatidylinositol 3-Kinases; Plant Extracts; Proteasome Inhibitors; Proto-Oncogene Proteins c-bcl-2; Quinazolines; Signal Transduction; Tetrazolium Salts; Thiazoles; Ubiquitin

2010
Evaluation of 3,4-dihydroquinazoline-2(1H)-thiones as inhibitors of alpha-MSH-induced melanin production in melanoma B16 cells.
    Bioorganic & medicinal chemistry, 2010, Feb-15, Volume: 18, Issue:4

    Topics: alpha-MSH; Animals; Cell Line, Tumor; Drug Evaluation, Preclinical; Magnetic Resonance Spectroscopy; Mass Spectrometry; Melanins; Melanoma, Experimental; Mice; Quinazolines; Spectroscopy, Fourier Transform Infrared

2010
SKLB1002, a novel potent inhibitor of VEGF receptor 2 signaling, inhibits angiogenesis and tumor growth in vivo.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2011, Jul-01, Volume: 17, Issue:13

    Topics: Angiogenesis Inhibitors; Animals; Apoptosis; Cell Line; Cell Line, Tumor; Cell Movement; Cell Proliferation; Endothelial Cells; Female; Hep G2 Cells; Humans; Melanoma, Experimental; Mice; Mice, Nude; Neoplasm Invasiveness; Neoplasms; Neovascularization, Pathologic; Neovascularization, Physiologic; Quinazolines; Signal Transduction; Thiadiazoles; Tumor Burden; Vascular Endothelial Growth Factor Receptor-2; Xenograft Model Antitumor Assays; Zebrafish

2011
Vascular endothelial growth factor receptor 2 inhibition in-vivo affects tumor vasculature in a tumor type-dependent way and downregulates vascular endothelial growth factor receptor 2 protein without a prominent role for miR-296.
    Anti-cancer drugs, 2012, Volume: 23, Issue:2

    Topics: Angiogenesis Inhibitors; Animals; Carcinoma, Lewis Lung; Cell Line, Tumor; Gene Expression Regulation, Neoplastic; Immunohistochemistry; Injections, Intraperitoneal; Male; Melanoma, Experimental; Mice; Mice, Inbred C57BL; MicroRNAs; Neovascularization, Pathologic; Piperidines; Quinazolines; Reverse Transcriptase Polymerase Chain Reaction; Vascular Endothelial Growth Factor Receptor-2; Xenograft Model Antitumor Assays

2012
Anti-invasive and metastatic activities of evodiamine.
    Biological & pharmaceutical bulletin, 2002, Volume: 25, Issue:11

    Topics: Animals; Antineoplastic Agents, Phytogenic; Carcinoma, Lewis Lung; Cell Movement; Colonic Neoplasms; Evodia; Female; Melanoma, Experimental; Mice; Mice, Inbred BALB C; Plant Extracts; Quinazolines

2002
Inhibition by evodiamine of hepatocyte growth factor-induced invasion and migration of tumor cells.
    Biological & pharmaceutical bulletin, 2004, Volume: 27, Issue:4

    Topics: Animals; Antineoplastic Agents, Phytogenic; Carcinoma, Lewis Lung; Cell Adhesion; Cell Line, Tumor; Cell Movement; Cell Proliferation; Colonic Neoplasms; Evodia; Hepatocyte Growth Factor; Melanoma, Experimental; Mice; Neoplasm Invasiveness; Plant Extracts; Quinazolines

2004
Cytotoxic and genotoxic effects of some substituted tetrazolo[1,5-c]quinazolines.
    Neoplasma, 2004, Volume: 51, Issue:6

    Topics: Animals; Antineoplastic Agents; Bacteria; Cell Proliferation; Drug Screening Assays, Antitumor; Melanoma, Experimental; Mice; Microbial Sensitivity Tests; Mutagenicity Tests; Quinazolines; Structure-Activity Relationship; Tetrazoles; Tumor Cells, Cultured

2004
Cytotoxic/antiproliferative effects of new [1,2,4]triazolo[4,3-c] quinazolines in tumor cell lines HeLa and B16.
    Neoplasma, 2006, Volume: 53, Issue:4

    Topics: Animals; Antineoplastic Agents; Cell Death; Cell Proliferation; DNA Damage; Drug Screening Assays, Antitumor; HeLa Cells; Humans; Inhibitory Concentration 50; Melanoma, Experimental; Mice; Quinazolines; Triazoles

2006
Promising carboranylquinazolines for boron neutron capture therapy: synthesis, characterization, and in vitro toxicity evaluation.
    European journal of medicinal chemistry, 2009, Volume: 44, Issue:1

    Topics: Antineoplastic Agents; Boranes; Boron Neutron Capture Therapy; Cell Line, Tumor; Humans; Melanoma, Experimental; Quinazolines; Spectrum Analysis; Structure-Activity Relationship

2009
[Synthesis and biological activities of 2,4-diamino-5-chloro-6-substituted quinazolines].
    Yao xue xue bao = Acta pharmaceutica Sinica, 1991, Volume: 26, Issue:11

    Topics: Animals; Anti-Bacterial Agents; Antimalarials; Antineoplastic Agents; Leukemia L1210; Melanoma, Experimental; Mice; Microbial Sensitivity Tests; Plasmodium berghei; Quinazolines; Streptococcus pneumoniae; Tumor Cells, Cultured

1991
Heterocyclic quinones. 17. A new in vivo active antineoplastic drug: 6,7-bis(1-aziridinyl)-4-[[3-(N,N-dimethylamino)propyl]amino]-5,8- quinazolinedione.
    Journal of medicinal chemistry, 1991, Volume: 34, Issue:1

    Topics: Animals; Antineoplastic Agents; Aziridines; Breast Neoplasms; Cell Division; Cell Line; Drug Screening Assays, Antitumor; Female; Humans; Leukemia L1210; Leukemia, Experimental; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Molecular Structure; Neoplasms, Experimental; Quinazolines; Sarcoma, Experimental; Structure-Activity Relationship

1991
Inhibitory effects of DN-9693 on platelet-enhanced tumor cell attachment to cultured endothelium.
    Invasion & metastasis, 1990, Volume: 10, Issue:1

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Blood Platelets; Calcium; Cells, Cultured; Endothelium, Vascular; Lung Neoplasms; Male; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Microscopy, Electron, Scanning; Neoplasms, Experimental; Platelet Activation; Platelet Aggregation Inhibitors; Pulmonary Artery; Quinazolines; Tumor Cells, Cultured

1990
A new antitumour agent, batracylin, selected by a preclinical solid tumour model.
    Drugs under experimental and clinical research, 1988, Volume: 14, Issue:9

    Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Colonic Neoplasms; Drug Screening Assays, Antitumor; Leukemia L1210; Leukemia P388; Melanoma, Experimental; Mice; Quinazolines

1988